110 related articles for article (PubMed ID: 28712115)
41. [Effects of Epstein-Barr virus latent membrane protein 1 on metastasis of human nasopharyngeal carcinoma cell lines].
Ou XB; Chen XY; Wu MH; Luo WR
Ai Zheng; 2008 Aug; 27(8):803-8. PubMed ID: 18710612
[TBL] [Abstract][Full Text] [Related]
42. [Primary adenoid cystic carcinoma of the nasopharynx and its relation to Epstein-Barr virus infection].
He JH; Zong YS; Zhang M; Zhong BL; Liang YJ; Liang XM
Zhonghua Bing Li Xue Za Zhi; 2003 Jun; 32(3):234-7. PubMed ID: 12882689
[TBL] [Abstract][Full Text] [Related]
43. Phenotypic alterations induced by the Hong Kong-prevalent Epstein-Barr virus-encoded LMP1 variant (2117-LMP1) in nasopharyngeal epithelial cells.
Lo AK; Huang DP; Lo KW; Chui YL; Li HM; Pang JC; Tsao SW
Int J Cancer; 2004 May; 109(6):919-25. PubMed ID: 15027126
[TBL] [Abstract][Full Text] [Related]
44. FosPeg® PDT alters the EBV miRNAs and LMP1 protein expression in EBV positive nasopharyngeal carcinoma cells.
Wu RW; Chu ES; Huang Z; Xu CS; Ip CW; Yow CM
J Photochem Photobiol B; 2013 Oct; 127():114-22. PubMed ID: 24013466
[TBL] [Abstract][Full Text] [Related]
45. Epstein-Barr virus latent membrane protein 1 (EBV-LMP1) and tumor proliferation rate as predictive factors of nasopharyngeal cancer (NPC) radiation response.
Gondhowiardjo S
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():323-31. PubMed ID: 10895175
[TBL] [Abstract][Full Text] [Related]
46. Epstein Barr virus associated pediatric nasopharyngeal carcinoma: its correlation with p53 and bcl-2 expression.
Preciado MV; Chabay PA; De Matteo EN; Gismondi MI; Rey G; Zubizarreta P
Med Pediatr Oncol; 2002 May; 38(5):345-8. PubMed ID: 11979459
[TBL] [Abstract][Full Text] [Related]
47. [Comparison of the Epstein-Barr virus infection and 30 bp-deleted LMP1 gene among 4 histologic types of nasopharyngeal carcinoma].
Zhang M; Zong YS; He JH; Zhong BL; Lin SX; Liang YJ
Zhonghua Bing Li Xue Za Zhi; 2003 Aug; 32(4):342-6. PubMed ID: 14514380
[TBL] [Abstract][Full Text] [Related]
48. [Effects of Epstein-Barr virus latent membrane protein 1(EBV-LMP1) on related factors of metastasis of nasopharyngeal carcinoma cell line CNE1].
Gou XM; Chen Y; Chen XY; Arrand JR
Ai Zheng; 2003 May; 22(5):481-5. PubMed ID: 12753707
[TBL] [Abstract][Full Text] [Related]
49. [Analysis of Epstein-Barr virus with BamHI "f" variant and XhoI-loss of LMP1 gene in nasopharyngeal carcinoma].
Han AJ; Zong YS; Zhang M; Cao SM; Lin SX; Liang YJ
Zhonghua Bing Li Xue Za Zhi; 2003 Dec; 32(6):534-8. PubMed ID: 14761599
[TBL] [Abstract][Full Text] [Related]
50. [Analysis of Epstein-Barr virus BamH I "f" variant in nodal metastasis of nasopharyngeal carcinoma].
Liu QY; Han AJ; Yang QX; Dong Y; Wu JH; You SY; Li MF
Zhonghua Bing Li Xue Za Zhi; 2008 Mar; 37(3):160-4. PubMed ID: 18788591
[TBL] [Abstract][Full Text] [Related]
51. Epstein-Barr virus latent membrane protein 1 induces the chemotherapeutic target, thymidine phosphorylase, via NF-kappaB and p38 MAPK pathways.
Chen CC; Chen LC; Liang Y; Tsang NM; Chang YS
Cell Signal; 2010 Jul; 22(7):1132-42. PubMed ID: 20214978
[TBL] [Abstract][Full Text] [Related]
52. [Expression and relationship of EBV LMP1, COX-2 and VEGF-C in nasopharyngeal carcinoma].
Yi X; Tang A; Qin Y; Wen W; Zhao W
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Feb; 24(3):126-8. PubMed ID: 20429385
[TBL] [Abstract][Full Text] [Related]
53. The A20 deubiquitinase activity negatively regulates LMP1 activation of IRF7.
Ning S; Pagano JS
J Virol; 2010 Jun; 84(12):6130-8. PubMed ID: 20392859
[TBL] [Abstract][Full Text] [Related]
54. Upregulation of special AT-rich-binding protein 1 by Epstein-Barr virus latent membrane protein 1 in human nasopharyngeal cells and nasopharyngeal cancer.
Endo K; Shackelford J; Aga M; Yoshizaki T; Pagano JS
J Gen Virol; 2013 Mar; 94(Pt 3):507-513. PubMed ID: 23223620
[TBL] [Abstract][Full Text] [Related]
55. Epstein-Barr virus latent membrane protein 1 is not associated with vessel density nor with hypoxia inducible factor 1 alpha expression in nasopharyngeal carcinoma tissue.
Benders AA; Tang W; Middeldorp JM; Greijer AE; Thorne LB; Funkhouser WK; Rathmell WK; Gulley ML
Head Neck Pathol; 2009 Dec; 3(4):276-82. PubMed ID: 20596845
[TBL] [Abstract][Full Text] [Related]
56. Immunohistochemical expression of latent membrane protein 1 (LMP1) and p53 in nasopharyngeal carcinoma: Moroccan experience.
Tabyaoui I; Serhier Z; Sahraoui S; Sayd S; Cadi R; Bennani OM; Benider A; Zamiati S; Tahiri JN
Afr Health Sci; 2013 Sep; 13(3):710-7. PubMed ID: 24250311
[TBL] [Abstract][Full Text] [Related]
57. Immune cells markers within local tumor microenvironment are associated with EBV oncoprotein in nasopharyngeal cancer.
Gondhowiardjo SA; Adham M; Rachmadi L; Atmakusuma TD; Tobing DL; Auzan M; Hariyanto AD; Sulaeman D; Permata TBM; Handoko
BMC Cancer; 2022 Aug; 22(1):887. PubMed ID: 35963999
[TBL] [Abstract][Full Text] [Related]
58. Epidermal growth factor receptor (EGFR) abundance correlates with p53 and Bcl-2 accumulation and patient age in a small cohort of North African nasopharyngeal carcinoma patients.
Bourouba M; Benyelles-Boufennara A; Terki N; Baraka-Kerboua E; Bouzid K; Touil-Boukoffa C
Eur Cytokine Netw; 2011 Mar; 22(1):38-44. PubMed ID: 21388911
[TBL] [Abstract][Full Text] [Related]
59. Distribution and clinical significance of circulating tumor cells in nasopharyngeal carcinoma.
Si Y; Lan G; Deng Z; Wang Y; Lu Y; Qin Y; Huang B; Yang Y; Weng J; Han X; Zhang B; Qin Y; Xiong W; Li B; Wu S
Jpn J Clin Oncol; 2016 Jul; 46(7):622-30. PubMed ID: 27162320
[TBL] [Abstract][Full Text] [Related]
60. Bcl-2 and LMP1 expression in nasopharyngeal carcinomas.
Sarac S; Akyol MU; Kanbur B; Poyraz A; Akyol G; Yilmaz T; Sungur A
Am J Otolaryngol; 2001; 22(6):377-82. PubMed ID: 11713720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
